Illumina (ILMN)
(Real Time Quote from BATS)
$114.30 USD
+7.51 (7.03%)
Updated Jun 6, 2024 01:10 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Illumina, Inc. [ILMN]
Reports for Purchase
Showing records 221 - 240 ( 361 total )
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Full 3Q15 Results Somewhat Encouraging - Multiple Paths to 2016 Improvement - FCF Impressive - Maintain OP - Upping PT to $160
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
3Q Preannouncement Driven By Weaker Desktop System Sales in EU - AsiaPac - Key High End Systems - Consumables Remain Solid - Lowering PT to $150
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Thoughts on PACB''s Sequel - Checks with Two Customers Suggest Sequel Instrument Threat is Minor - Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Thoughts on PACB''s Sequel - Checks with Two Customers Suggest Sequel Instrument Threat is Minor - Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z